aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
PROCEPT BioRobotics Corporation specializes in manufacturing advanced medical and surgical equipment, with a focus on autonomous surgical robots for treating benign prostatic hyperplasia (BPH). Their flagship technology, Aquablation therapy, combines imaging clarity, robotic precision, and water power to offer a novel approach to BPH treatment. This innovative therapy aims to provide effective, safe, and durable outcomes across various prostate sizes and shapes.
The company's Aquablation therapy represents a significant advancement in BPH surgical treatment, addressing the traditional compromise between safety and efficacy. PROCEPT BioRobotics has positioned itself as a pioneer in this field, offering a solution that delivers consistent results regardless of surgeon experience. Their technology has the potential to establish a new standard in BPH treatment, serving patients worldwide.
Operating Status
Public
Ownership Type(s)
Public
Main Product(s)
Surgical Robots
Technology
Robotics
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Procept Biorobotics founded?
Procept Biorobotics was founded in 2007.
Where is Procept Biorobotics's headquarters located?
Procept Biorobotics's headquarters is located in San José, CA, US.
When was Procept Biorobotics's last funding round?
Procept Biorobotics's most recent funding round was for $150M (USD) in August 2023.
How many employees does Procept Biorobotics have?
Procept Biorobotics has 428 employees as of Feb 6, 2024.
How much has Procept Biorobotics raised to-date?
As of July 05, 2023, Procept Biorobotics has raised a total of $645.3M (USD) since Aug 1, 2023.
Add Comparison
Total Raised to Date
$645.3M
USD
Last Update Aug 1, 2023
Last Deal Details
$150M
USD
Aug 1, 2023
Post Ipo Equity
Total Employees Over Time
428
As of Feb 2024
Procept Biorobotics Address
150 Baytech Dr
San José,
California
951342302
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts